Mumbai, Dec 21: Pharma major, Glenmark Pharma said that it has launched the first triple fixed-dose combination Teneligliptin with Pioglitazone and Metformin in India. Teneligliptin is a widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor). This FDC has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg) + Pioglitazone (15 mg) + Metformin (500mg/1000mg) in a sustained release (SR) formulation. This offers patients with Type 2 diabetes the convenience of once daily dosing to improve their glycemic […]
Glenmark Pharma launches Minocycline gel uniindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uniindia.com Daily Mail and Mail on Sunday newspapers.
Purulia recorded 30 mm rainfall in 24 hours till 8.30 am on Thursday as other parts of Gangetic West Bengal largely remained dry, , Asthama, glenmark pharmaceuticals